Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival - Rinke, A; Wittenberg, M; Schade-Brittinger, C (Neuroendocrinology, 2017)
et al.